Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.94 USD | -0.76% | -1.40% | -4.08% |
04-25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Sales 2024 * | 535M 42.85B | Sales 2025 * | 577M 46.18B | Capitalization | 794M 63.6B |
---|---|---|---|---|---|
Net income 2024 * | 38M 3.04B | Net income 2025 * | 51M 4.08B | EV / Sales 2024 * | 1.73 x |
Net Debt 2024 * | 132M 10.57B | Net Debt 2025 * | 79M 6.32B | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
15.5
x | Employees | 3,500 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.24% | Free-Float | 98.9% |
Latest transcript on Core Laboratories Inc.
1 day | -0.76% | ||
1 week | -1.40% | ||
Current month | -0.82% | ||
1 month | +2.67% | ||
3 months | +0.71% | ||
6 months | -24.27% | ||
Current year | -4.08% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 27/06/23 |
Director/Board Member | 71 | 31/12/19 | |
Director/Board Member | 74 | 31/12/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 16.94 | -0.76% | 522,902 |
25/04/24 | 17.07 | +3.27% | 693,893 |
24/04/24 | 16.53 | -2.71% | 412,749 |
23/04/24 | 16.99 | +0.12% | 425,546 |
22/04/24 | 16.97 | -1.22% | 307,758 |
Delayed Quote Nyse, April 26, 2024 at 09:02 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.08% | 794M | |
+14.61% | 17.2B | |
0.00% | 6.8B | |
-12.39% | 2.88B | |
-11.15% | 2.72B | |
-31.21% | 1.74B | |
+5.00% | 1.25B | |
-7.31% | 1.06B | |
-6.67% | 870M | |
+0.62% | 757M |
- Stock Market
- Equities
- CLB Stock